Insider Transactions

What Neon Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	0
Sells	0	0
Total trades	0	0

Shares traded

	3 months	12 months
Acquired	0	0
Disposed	0	0
Net activity	+0	+0

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Al-Wakeel Yasir B.	Chief Financial Officer	May 06	Disposition to Issuer · D	−196,965	—	—	0
Siegel Jolie	VP, General Counsel	May 06	Disposition to Issuer · D	−161,821	—	—	0
Gaynor Richard	President of R&D	May 06	Disposition to Issuer · D	−210,410	—	—	0
Sherwin Stephen A	Director	May 06	Disposition to Issuer · D	−45,000	—	—	0
O'Dowd Hugh	President & CEO	May 06	Disposition to Issuer · D	−776,085	—	—	0
Lander Eric S	Director	May 06	Disposition to Issuer · D	−134,000	—	—	0
Pfeffer Cary	Director	May 06	Disposition to Issuer · D	+0	—	—	0
Tepper Robert I	Director	May 06	Disposition to Issuer · D	−9,741,636	—	—	0
Access Industries Holdings Llc	10% owner	Mar 24	Open-market sale · S	−84,286	$2.19	−$185K	856,304
Access Industries Holdings Llc	10% owner	Mar 24	Open-market sale · S	−117,400	$2.20	−$259K	1,896,176
Access Industries Holdings Llc	10% owner	Mar 23	Open-market sale · S	−50,358	$2.17	−$109K	940,590
Access Industries Holdings Llc	10% owner	Mar 20	Open-market sale · S	−84,339	$2.22	−$187K	2,013,576
Access Industries Holdings Llc	10% owner	Mar 19	Open-market sale · S	−9,050	$2.51	−$22.8K	990,948
Al-Wakeel Yasir B.	Chief Financial Officer	Feb 29	Withheld — tax / exercise cost · F	−4,891	$1.50	−$7.34K	196,965
Siegel Jolie	VP, General Counsel	Feb 29	Withheld — tax / exercise cost · F	−2,845	$1.50	−$4.27K	161,821
Gaynor Richard	President of R&D	Feb 29	Withheld — tax / exercise cost · F	−5,625	$1.50	−$8.44K	210,410
O'Dowd Hugh	President & CEO	Feb 29	Withheld — tax / exercise cost · F	−9,783	$1.50	−$14.7K	776,085
Al-Wakeel Yasir B.	Chief Financial Officer	Feb 25	Withheld — tax / exercise cost · F	−5,385	$1.51	−$8.13K	201,856
Siegel Jolie	VP, General Counsel	Feb 25	Withheld — tax / exercise cost · F	−5,334	$1.51	−$8.05K	164,666
Gaynor Richard	President of R&D	Feb 25	Withheld — tax / exercise cost · F	−5,465	$1.51	−$8.25K	216,035

Page 1 of 3 · showing the 20 most recent Sign up free to view all 48 transactions and filter by insider →

Comments